Nalu is a medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic neuropathic pain. The Nalu Neurostimulation System delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The Nalu system was designed to address major unmet needs in the treatment of chronic neuropathic pain and provide a differentiated value proposition for patients and physicians.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/19/22 | $104,000,000 |
Advent Life Sciences Aperture Venture Partners Decheng Capital Endeavour Vision Gilde Healthcare Partners  Longitude Capital MVM Partners Pura Vida Investments | undisclosed | |
| 01/03/24 | $65,000,000 | Series E |
Advent Life Sciences Aperture Venture Partners Decheng Capital Endeavor Vision Glide Healthcare Partners Longitude Capital MVM Partners Novo Holdings Pura Vida Investments | undisclosed |
